Old Web
English
Sign In
Acemap
>
authorDetail
>
Barbara Koetz
Barbara Koetz
University of Manchester
Medicine
Pathology
Colchicine
Lethargy
Fluorodeoxyglucose
4
Papers
4
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A multicenter, open label, first-in-human study of an oncolytic viral vector expressing an agonistic anti-CD40 antibody (NG-350A) in patients with epithelial tumors (FORTITUDE).
2019
Journal of Clinical Oncology
Aung Naing
Ecaterina Ileana Dumbrava
Ravi Murthy
Funda Meric-Bernstam
Andrew Fox
David Krige
Jo Carter
Brian Robert Champion
Paul Cockle
Barbara Koetz
Hilary McElwaine-Johnn
Show All
Source
Cite
Save
Citations (0)
A PET imaging study of the vascular disruptive agent OXi4503 to confirm in vivo mechanism of action in a phase I trial
2009
Journal of Clinical Oncology
Patricia Price
Marie-Claude Asselin
Barbara Koetz
C. Dickinson
Natalie Charnley
Paul Lorigan
Juan W. Valle
Michael R.L. Stratford
Gordon Rustin
Azeem Saleem
Show All
Source
Cite
Save
Citations (1)
Interim results from a phase I trial of the vascular disrupting agent OXi4503
2007
Molecular Cancer Therapeutics
D. M. Patterson
Phillip Ross
Barbara Koetz
Azeem Saleem
Mike Stratford
James Stirling
Anwar Padhani
Marie-Claude Asselin
Patricia Price
Gordon Rustin
Show All
Source
Cite
Save
Citations (0)
Positron Emission Tomography
2006
Barbara Koetz
Patricia Price
Show All
Source
Cite
Save
Citations (3)
1